{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T19:13:09Z","timestamp":1779909189938,"version":"3.53.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-025-04126-3","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T11:50:16Z","timestamp":1750333816000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["New-onset drug-resistant epilepsy in type 1 diabetes mellitus patient following COVID-19 vaccination: suspicious for autoimmune pathogenesis"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5881-9607","authenticated-orcid":false,"given":"Sally","family":"Shaaban","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmeen A.","family":"Kishk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amani","family":"Nawito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Hamdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadeer Elsaeed","family":"AboElfarh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Elfieshy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Eladrousi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Baghdadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa El Sayed","family":"Elktob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Elmenshawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,19]]},"reference":[{"key":"4126_CR1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fnana.2018.00025","volume":"12","author":"Q Wu","year":"2018","unstructured":"Wu Q, Zhao CW, Long Z, Xiao B, Feng L. Anatomy based networks and topology alteration in seizure-related cognitive outcomes. Front Neuroanat. 2018;12:25.","journal-title":"Front Neuroanat"},{"key":"4126_CR2","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/epi.13709","volume":"58","author":"IE Scheffer","year":"2017","unstructured":"Scheffer IE, Berkovic S, Capovilla G, Connolly MB, French J, Guilhoto L, Hirsch E, Jain S, Mathern GW, Mosh\u00e9 SL. ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58:512\u201321.","journal-title":"Epilepsia"},{"key":"4126_CR3","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/ni0602-500","volume":"3","author":"M Levite","year":"2002","unstructured":"Levite M. Autoimmune epilepsy. Nat Immunol. 2002;3:500\u2013500.","journal-title":"Nat Immunol"},{"key":"4126_CR4","doi-asserted-by":"publisher","first-page":"762743","DOI":"10.3389\/fimmu.2021.762743","volume":"12","author":"M Levite","year":"2022","unstructured":"Levite M, Goldberg H. Autoimmune epilepsy-novel Multidisciplinary analysis,\u00a0discoveries and insights. Front Immunol. 2022;12:762743.","journal-title":"Front Immunol"},{"key":"4126_CR5","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s13311-019-00750-3","volume":"16","author":"KS Husari","year":"2019","unstructured":"Husari KS, Dubey D. Autoimmune epilepsy. Neurotherapeutics. 2019;16:685\u2013702.","journal-title":"Neurotherapeutics"},{"key":"4126_CR6","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1093\/brain\/awaa362","volume":"144","author":"C Steriade","year":"2021","unstructured":"Steriade C, Titulaer MJ, Vezzani A, Sander JW, Thijs RD. The association between systemic autoimmune disorders and epilepsy and its clinical implications. Brain. 2021;144:372\u201390.","journal-title":"Brain"},{"issue":"2","key":"4126_CR7","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1152\/physrev.00010.2016","volume":"97","author":"J Dalmau","year":"2017","unstructured":"Dalmau J, Geis C, Graus F. Autoantibodies to synaptic receptors and neuronal cell surface proteins in autoimmune diseases of the central nervous system. Physiol Rev. 2017;97(2):839\u201387.","journal-title":"Physiol Rev."},{"key":"4126_CR8","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41582-020-0359-x","volume":"16","author":"F Graus","year":"2020","unstructured":"Graus F, Saiz A, Dalmau J. GAD antibodies in neurological disorders\u2014insights and challenges. Nat Rev Neurol. 2020;16:353\u201365.","journal-title":"Nat Rev Neurol"},{"key":"4126_CR9","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1358\/dof.2011.36.11.1710754","volume":"36","author":"R Towns","year":"2011","unstructured":"Towns R, Pietropaolo M. GAD65 autoantibodies and its role as biomarker of Type 1 diabetes and Latent Autoimmune Diabetes in Adults (LADA). Drugs of the future. 2011;36:847.","journal-title":"Drugs of the future"},{"key":"4126_CR10","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1093\/brain\/awac404","volume":"146","author":"AR Tr\u00f6scher","year":"2023","unstructured":"Tr\u00f6scher AR, Mair KM, Verd\u00fa de Juan L, K\u00f6ck U, Steinmaurer A, Baier H, Becker A, Bl\u00fcmcke I, Finzel M, Geis C. Temporal lobe epilepsy with GAD antibodies: neurons killed by T cells not by complement membrane attack complex. Brain. 2023;146:1436\u201352.","journal-title":"Brain"},{"issue":"10","key":"4126_CR11","doi-asserted-by":"publisher","first-page":"e182","DOI":"10.1111\/epi.18086","volume":"65","author":"HH Zhao-Fleming","year":"2024","unstructured":"Zhao-Fleming HH, Guo Y, Britton JW, Dubey D, Smith KM. Outcomes of surgical resection and vagus nerve stimulation in patients with medically refractory epilepsy and glutamic acid decarboxylase 65 antibody positivity. Epilepsia. 2024;65(10):e182\u20139.","journal-title":"Epilepsia."},{"key":"4126_CR12","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1136\/jnnp-2020-325275","volume":"92","author":"A Budhram","year":"2021","unstructured":"Budhram A, Sechi E, Flanagan EP, et al. Clinical spectrum of high-titre GAD65 antibodies. J Neurol Neurosurg Psychiatry. 2021;92:645\u201354.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4126_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurop.2023.100144","volume":"4","author":"A Moreno-Est\u00e9banez","year":"2024","unstructured":"Moreno-Est\u00e9banez A, Marinas A, Ruiz IG, Eizaguirre AG, Reurich-G\u00f3mez N, Dur\u00e1n SB, Bilbao MM, Rodr\u00edguez-Antig\u00fcedad A. Autoimmune-associated epilepsy in an outpatient epilepsy clinic: A retrospective study. Neurology Perspectives. 2024;4: 100144.","journal-title":"Neurology Perspectives"},{"key":"4126_CR14","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/imm.13443","volume":"165","author":"Y Chen","year":"2022","unstructured":"Chen Y, Xu Z, Wang P, Li XM, Shuai ZW, Ye DQ, Pan HF. New-onset autoimmune phenomena post-COVID-19 vaccination. Immunology. 2022;165:386\u2013401.","journal-title":"Immunology"},{"key":"4126_CR15","doi-asserted-by":"publisher","first-page":"5720","DOI":"10.1007\/s00415-022-11234-4","volume":"269","author":"GM Asioli","year":"2022","unstructured":"Asioli GM, Muccioli L, Barone V, Giacomozzi S, Rossi S, Silvestri T, Spinardi L, Mastrangelo V, Bernab\u00e8 G, Leta C. Anti-LGI1 encephalitis following COVID-19 vaccination: a case series. J Neurol. 2022;269:5720\u20133.","journal-title":"J Neurol"},{"key":"4126_CR16","first-page":"2","volume":"3","author":"G Giannotta","year":"2018","unstructured":"Giannotta G, Giannotta N. Vaccines and neuroinflammation. Int J Pub Health Safe. 2018;3:2.","journal-title":"Int J Pub Health Safe"},{"key":"4126_CR17","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3390\/vaccines12030334","volume":"12","author":"YC Tyan","year":"2024","unstructured":"Tyan YC, Chuang SC, Ho TC, Chuang KP, Yang MH. SARS-CoV-2 Vaccine Safety and Autoimmune Response. Vaccines. 2024;12:334. https:\/\/doi.org\/10.3390\/vaccines12030334.","journal-title":"Vaccines."},{"key":"4126_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.01143","volume":"9","author":"M Falip","year":"2019","unstructured":"Falip M, Rodriguez-Bel L, Jaraba S. Hippocampus and insula are targets in epileptic patients with glutamic acid decarboxylase antibodies. Front Neurol. 2019;9: 428645.","journal-title":"Front Neurol"},{"key":"4126_CR19","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.yebeh.2018.01.021","volume":"80","author":"A Daif","year":"2018","unstructured":"Daif A, Lukas RV, Issa NP, Javed A, VanHaerents S, Reder AT, Tao JX, Warnke P, Rose S, Towle VL. Antiglutamic acid decarboxylase 65 (GAD65) antibody-associated epilepsy. Epilepsy Behav. 2018;80:331\u20136.","journal-title":"Epilepsy Behav"},{"key":"4126_CR20","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1007\/s00415-020-09807-2","volume":"267","author":"B Joubert","year":"2020","unstructured":"Joubert B, Belbezier A, Haesebaert J, Rheims S, Ducray F, Picard G, Rogemond V, Psimaras D, Berzero G, Desestret V. Long-term outcomes in temporal lobe epilepsy with glutamate decarboxylase antibodies. J Neurol. 2020;267:2083\u20139.","journal-title":"J Neurol"},{"key":"4126_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00579","volume":"9","author":"K-M M\u00e4kel\u00e4","year":"2018","unstructured":"M\u00e4kel\u00e4 K-M, Hietaharju A, Brander A, Peltola J. Clinical management of epilepsy with glutamic acid decarboxylase antibody positivity: the interplay between immunotherapy and anti-epileptic drugs. Front Neurol. 2018;9: 393172.","journal-title":"Front Neurol"},{"key":"4126_CR22","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1111\/epi.16571","volume":"61","author":"C Steriade","year":"2020","unstructured":"Steriade C, Britton J, Dale RC, Gadoth A, Irani SR, Linnoila J, McKeon A, Shao XQ, Venegas V, Bien CG. Acute symptomatic seizures secondary to autoimmune encephalitis and autoimmune-associated epilepsy: conceptual definitions. Epilepsia. 2020;61:1341\u201351.","journal-title":"Epilepsia"},{"key":"4126_CR23","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.seizure.2020.07.019","volume":"81","author":"M Falip","year":"2020","unstructured":"Falip M, Jaraba S, Rodr\u00edguez-Bel L, Casta\u00f1er S, Mora J, Arroyo P, Miro J, Sala-Padr\u00f3 J, Mart\u00ednez-Y\u00e9lamos S, Casasnovas C. Seizures and epilepsy of autoimmune origin: A long-term prospective study. Seizure. 2020;81:157\u201365.","journal-title":"Seizure"},{"key":"4126_CR24","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1212\/WNL.0000000000000383","volume":"82","author":"M Toledano","year":"2014","unstructured":"Toledano M, Britton J, McKeon A, Shin C, Lennon V, Quek A, So E, Worrell G, Cascino G, Klein C. Utility of an immunotherapy trial in evaluating patients with presumed autoimmune epilepsy. Neurology. 2014;82:1578\u201386.","journal-title":"Neurology"},{"key":"4126_CR25","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1093\/brain\/awx323","volume":"141","author":"J Thompson","year":"2018","unstructured":"Thompson J, Bi M, Murchison AG, Makuch M, Bien CG, Chu K, Farooque P, Gelfand JM, Geschwind MD, Hirsch LJ. The importance of early immunotherapy in patients with faciobrachial dystonic seizures. Brain. 2018;141:348\u201356.","journal-title":"Brain"},{"key":"4126_CR26","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1002\/ana.21917","volume":"67","author":"MP Malter","year":"2010","unstructured":"Malter MP, Helmstaedter C, Urbach H, Vincent A, Bien CG. Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis. Ann Neurol. 2010;67:470\u20138.","journal-title":"Ann Neurol"},{"key":"4126_CR27","first-page":"e45344","volume":"15","author":"E Akkoyun","year":"2023","unstructured":"Akkoyun E, Akyuz F, Cavus B, Gunduz T, K\u00fcrt\u00fcnc\u00fc M. Concomitant Crohn\u2019s Disease And Anti-Glutamic Acid Decarboxylase (Gad)-Associated Autoimmune Encephalitis: A Case Report. Cureus. 2023;15:e45344.","journal-title":"Cureus"},{"key":"4126_CR28","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jneuroim.2009.04.010","volume":"211","author":"L Errichiello","year":"2009","unstructured":"Errichiello L, Perruolo G, Pascarella A, Formisano P, Minetti C, Striano S, Zara F, Striano P. Autoantibodies to glutamic acid decarboxylase (GAD) in focal and generalized epilepsy: a study on 233 patients. J Neuroimmunol. 2009;211:120\u20133.","journal-title":"J Neuroimmunol"},{"key":"4126_CR29","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1111\/j.1528-1167.2009.02325.x","volume":"51","author":"S Liimatainen","year":"2010","unstructured":"Liimatainen S, Peltola M, Sabater L, Fallah M, Kharazmi E, Haapala AM, Dastidar P, Knip M, Saiz A, Peltola J. Clinical significance of glutamic acid decarboxylase antibodies in patients with epilepsy. Epilepsia. 2010;51:760\u20137.","journal-title":"Epilepsia"},{"key":"4126_CR30","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1474-4422(13)70282-5","volume":"13","author":"N Gresa-Arribas","year":"2014","unstructured":"Gresa-Arribas N, Titulaer MJ, Torrents A, Aguilar E, McCracken L, Leypoldt F, Gleichman AJ, Balice-Gordon R, Rosenfeld MR, Lynch D. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. The Lancet Neurology. 2014;13:167\u201377.","journal-title":"The Lancet Neurology"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04126-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04126-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04126-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T11:50:17Z","timestamp":1750333817000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-025-04126-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,19]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4126"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04126-3","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,19]]},"assertion":[{"value":"23 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient has provided written informed consent for the publication of this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"251"}}